HIV

Latest News

FDA Approves Biktarvy for Patients With HIV Previously Treated With Antiretroviral Therapy
FDA Approves Biktarvy for Patients With HIV Previously Treated With Antiretroviral Therapy

August 5th 2025

FDA approves Biktarvy for HIV treatment in patients not virologically suppressed, enhancing options for those restarting antiretroviral therapy.

Once Monthly Oral PrEP Medication Will Advance to Phase 3 Study
Once Monthly Oral PrEP Medication Will Advance to Phase 3 Study

July 16th 2025

FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1
FDA to Evaluate Merck’s Doravirine, Islatravir Regimen for HIV-1

July 10th 2025

FDA Approves Lenacapavir for Prevention of HIV
FDA Approves Lenacapavir for Prevention of HIV

June 18th 2025

Home Administration of Long-Acting HIV Therapy is Safe, Effective
Home Administration of Long-Acting HIV Therapy is Safe, Effective

May 3rd 2025

More News

© 2025 MJH Life Sciences

All rights reserved.